Metabotropic glutamate receptors in the basal ganglia motor circuit

@article{Conn2005MetabotropicGR,
  title={Metabotropic glutamate receptors in the basal ganglia motor circuit},
  author={P. Jeffrey Conn and Giuseppe Battaglia and Michael J. Marino and Ferdinando Nicoletti},
  journal={Nature Reviews Neuroscience},
  year={2005},
  volume={6},
  pages={787-798}
}
In recent years there have been tremendous advances in our understanding of the circuitry of the basal ganglia and our ability to predict the behavioural effects of specific cellular changes in this circuit on voluntary movement. These advances, combined with a new understanding of the rich distribution and diverse physiological roles of metabotropic glutamate receptors in the basal ganglia, indicate that these receptors might have a key role in motor control and raise the exciting possibility… 

Figures and Tables from this paper

Metabotropic Glutamate Receptors and Parkinson’s Disease: Basic and Preclinical Neuroscience
TLDR
Data is provided showing that drugs acting on mGlu receptors can alleviate PD motor symptoms and reduce levodopa-induced dyskinesia in animal models of PD and recent clinical trials that confirm these findings.
Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease.
  • M. Amalric
  • Biology, Psychology
    Current opinion in pharmacology
  • 2015
Metabotropic glutamate receptors: physiology, pharmacology, and disease.
TLDR
The widespread expression of mGluRs makes these receptors particularly attractive drug targets, and recent studies continue to validate the therapeutic utility of m GluR ligands in neurological and psychiatric disorders such as Alzheimer's disease, Parkinson's Disease, anxiety, depression, and schizophrenia.
Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease.
TLDR
The role of metabotropic glutamate receptors within the basal ganglia is reviewed and the potential for modulation of metabotrop glutamate receptors as a treatment for PD is discussed.
Glutamatergic Receptors in Parkinson’s Disease
TLDR
In this chapter, recent progress in the research of GluRs is reviewed with special emphasis on the molecular diversity of the mGluR system and its implications in the physiopathology of PD.
Striatal cholinergic interneuron regulation and circuit effects
TLDR
Recent advances in understanding of the factors affecting the excitability of these neurons through acute effects and long term changes in their synaptic inputs are summarized.
Role of Metabotropic Glutamate Receptors in Neurological Disorders
TLDR
Preclinical and clinical data have shown that, in the CNS, mGluRs are able to modulate presynaptic neurotransmission by fine-tuning neuronal firing and neurotransmitter release in a dynamic, activity-dependent manner.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 166 REFERENCES
Modulation of the basal ganglia by metabotropic glutamate receptors: potential for novel therapeutics.
  • M. Marino, P. Conn
  • Biology, Psychology
    Current drug targets. CNS and neurological disorders
  • 2002
TLDR
Data from behavioral, neurochemical, neuroanatomical and electrophysiological studies has begun to reveal the functional roles that the metabotropic glutamate receptors play in modulating the basal ganglia circuit, and suggests that compounds selectively targeting these receptors may provide novel therapies for a variety of disorders including Parkinson's disease, addiction, and epilepsy.
Functional and pathophysiological models of the basal ganglia
Glutamate Receptors and Parkinson’s Disease
TLDR
Analysis of the effects of glutamate receptor ligands in the basal ganglia circuit suggests that both ionotropic and metabotropic glutamate receptors could have antiparkinsonian actions, and NMDA receptor antagonists that selectively target the NR2B subunit and antagonists of the metabotrop glutamate receptor mGluR5 appear to hold promise and deserve future attention.
Metabotropic Glutamate 5 Receptor Blockade Alleviates Akinesia by Normalizing Activity of Selective Basal-Ganglia Structures in Parkinsonian Rats
TLDR
It is reported that rats with partial bilateral dopamine lesions exhibit akinetic deficits associated with dramatically increased neuronal metabolic activity in selective structures of the basal ganglia such as the subthalamic nucleus and the substantia nigra pars reticulata, but not in the entopeduncular nucleus.
Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1
TLDR
Mice deficient in mGluRl have severe motor coordination and spatial learning deficits, and show impaired cerebellar long-term depression and hippocampal mossy fibre long- term potentiation, and should be valuable models for studying synaptic plasticity.
Activation of Group II Metabotropic Glutamate Receptors Inhibits Synaptic Excitation of the Substantia Nigra Pars Reticulata
TLDR
It is reported that group II metabotropic glutamate receptors (mGluRs) are presynaptically localized on STN terminals and that activation of these receptors inhibits excitatory transmission at STN synapses.
...
1
2
3
4
5
...